SK
Shibban Krishen Ganju
About Shibban Krishen Ganju
Data last updated:
Shibban Krishen Ganju is a Director at Atrimed Pharmaceuticals Private Limited (since 2010), Director at Mahila Healthcare Private Limited (since 2020) and Designated Partner at Damle & Ganju Health Consultants Llp (since 2020). The companies operate in Healthcare, Events and Entertainment and Agriculture. The largest current company by reported revenue is Atrimed Pharmaceuticals Private Limited at ₹24.09 Cr (FY 2024). Earlier, Shibban Krishen Ganju was an Additional Director at Goodwill Auctions & Experiences Private Limited (2016–2025) and Director at Moksha-Yug Access India Private Limited (2006–2008) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Mar 2010 | 2003 | ₹24.09 Cr (FY 2024) | Active | |
| Director | 23 Jan 2020 | 2020 | Active | ||
| Designated Partner | 13 Jan 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 20 Oct 2016 | 2016 | ₹86.9 Lakh (FY 2017) | Under Process Of Striking Off | |
| Director | 18 Aug 2006 | 2005 | ₹8,398 (FY 2021) | Active | |
| Additional Director | 06 Mar 2018 | 2013 | ₹71.91 Cr (FY 2025) | Active | |
| Director | 16 Jun 2010 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shibban Krishen Ganju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hrishikesh Damle | 00574119 | Atrimed Pharmaceuticals Private Limited , Mahila Healthcare Private Limited and 1 more | Director |
| Latha Damle | 07038353 | Atrimed Pharmaceuticals Private Limited | Director |
| Rishi Ganju | 09313050 | Atrimed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shibban Krishen Ganju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shibban Krishen Ganju
Shibban Krishen Ganju currently holds 3 directorships: Atrimed Pharmaceuticals Private Limited (Director, since 25 Mar 2010, revenue ₹24.09 Cr (FY 2024)); Mahila Healthcare Private Limited (Director, since 23 Jan 2020); Damle & Ganju Health Consultants Llp (Designated Partner, since 13 Jan 2020).
Shibban Krishen Ganju was first appointed on 18 Aug 2006 as Director at Moksha-Yug Access India Private Limited. The most recent appointment on record is 23 Jan 2020 at Mahila Healthcare Private Limited.
Shibban Krishen Ganju held 4 earlier board appointments: Goodwill Auctions & Experiences Private Limited (Additional Director, 20 Oct 2016 to 01 Jul 2025); Moksha-Yug Access India Private Limited (Director, 18 Aug 2006 to 23 Feb 2008); C Square Healthcare Private Limited (Additional Director, 06 Mar 2018 to 18 Jun 2018); Chicago India Health Infrastructure Private Limited (Director, from 16 Jun 2010).
The current boards of Shibban Krishen Ganju's companies include Hrishikesh Damle (Atrimed Pharmaceuticals Private Limited), Latha Damle (Atrimed Pharmaceuticals Private Limited), Rishi Ganju (Atrimed Pharmaceuticals Private Limited).